Inflammatory Bowel Disease (IBD) Treatment Market, By Type (Crohns Disease, and Ulcerative Colitis), By Route of Administration (Oral, and Injectable), By Distribution Channel (Online Pharmacy, Retail Pharmacy, and Hospital Pharmacy), and By Geography (NA, EU, APAC, LATAM and MEA) Analysis, Share, Trends, Size, & Forecast From 2020 2026
- Published Date: 2020-10-13
- Report ID: 1809
- Pages: 154
-
Format:
REPORT HIGHLIGHT
Inflammatory Bowel Disease (IBD) Treatment market was valued at USD 15.87 billion by 2019, growing with 4.1% CAGR during the forecast period, 2020-2026
Market Dynamics
A rise in the number of drugs available in clinical tests, growing prevalence of inflammatory bowel disease (IBD), and rising government initiatives related to the analysis of the causes and effective novel drug developments are the major factors driving the growth of global IBD treatment market. In addition, the high prevalence of and growing occurrence of ulcerative colitis and Chron's disease are likely to create growth opportunities in the IBD treatment market in the projected timeframe. However, stringent drug regulatory policies and lack of treatment effectiveness are predicted to impede the market growth in the coming future.
Types Takeaway
The Crohns disease type segment accounted for the majority of share in 2019 and is expected to rise at an impressive growth rate during the forecast period. This growth is primarily owing to the growing prevalence of the condition. As per a published article in 2018 in Jobson Medical Information LLC, the occurrence of Chrons disease was found to be approximately 3.1 to 14.6 cases per 100,000 people each year and the incidence in the U.S. was around 201 cases per 100,000 adults. On the other hand, the ulcerative colitis segment is expected to grow at the fastest rate throughout the forecast majorly due to presence of strong pipeline for the treatment of ulcerative colitis.
Route of Distribution Takeaway
The injectables route of administration segment is considered to be the largest due to its efficacy. Additionally, the development of biosimilars such as Inflectra is likely to boost the segmental market growth. Along with injectables, the oral route segment is projected to be the fastest-growing market by 2030 owing to the presence of strong pipeline products. The ASAs sub-segment of the oral route of administration subjugated the market in 2019 and the AK inhibitors sub-segment is estimated to grow at the fastest pace during the period of forecast.
Distribution Channel Takeaway
By distribution channel, the hospital pharmacy segment including both out-patient and in-patient subjugated the market in 2018 and is predicted to grow exponentially throughout the forecast. This is majorly owing to the rising prevalence of ulcerative colitis and Crohns disease coupled with a growing total number of hospitalizations all across the globe. On the other hand, the online pharmacy is predicted to be the fastest-growing segmental market by the end of 2030. The increasing demand and rising trend of online purchasing are contributing to the growth of online pharmacy segment. In addition, customers find online pharmacy beneficial due to the availability of various offers and discounts.
Regional Takeaway
Presently, the North America market for IBD treatment is playing a dominant role owing to the presence of major market players and sophisticated healthcare infrastructure. The region is expected to lead the market during the period of forecast due to rising prevalence of Chrons diseases & ulcerative colitis and the growing increasing geriatric population in the U.S. On the other hand, the Asia Pacific region is estimated to grow at the fastest pace by the end of 2030 due to increasing product approvals in this region.
Key players of the market include:
Pfizer Inc.
AbbVie Inc.
Cosmo Pharmaceuticals
UCB S.A.
Innovate Biopharmaceuticals
Gilead Sciences
Celgene Corporation
Celltrion Healthcare Co., Ltd.
Johnson & Johnson Services Inc.
Takeda Pharmaceutical Company Limited
The market size and forecast for each segment and sub-segments has been considered as below:
Historical Year 2015 to 2018
Base Year 2019
Estimated Year 2020
Projected Year 2026
TARGET AUDIENCE
Traders, Distributors, and Suppliers
Manufacturers
Government and Regional Agencies
Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION
Oral
o 5-Aminosalicylic Acid
o Corticosteroids
o Janus Kinase (JAK) Inhibitors
o Others
Injectable
o Tumor Necrosis Factor (TNF) Inhibitors
o Interleukin inhibitors
o Anti-integrin
o Others
GLOBAL INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET, BY TYPE
Chrons Disease
Ulcerative Colitis
Others
GLOBAL INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET, BY DISTRIBUTION CHANNEL
Retail Pharmacy
Hospital Pharmacy
Online Pharmacy
Others
GLOBAL INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET, BY REGION
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Singapore
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Rest of LATAM
Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Rest of MEA
TABLE OF CONTENT
1. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Route of Administration
2.1.2. Market Snippet by Type
2.1.3. Market Snippet by Distribution Channel
2.1.4. Market Snippet by Region
2.2. Competitive Insights
3. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT INDUSTRY STUDY
4.1. Porters Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
4.5. COVID-19 Impact Analysis
4.5.1. Pre-COVID-19 Impact Analysis
4.5.2. Post-COVID-19 Impact Analysis
5. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer
5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis
6. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET BY ROUTE OF ADMINISTRATION
6.1. Overview
6.1.1. Segment Share Analysis, By Route of Administration, 2019 & 2026 (%)
6.2. Oral
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.2.3. 5-Aminosalicylic Acid
6.2.3.1. Overview
6.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.2.4. Corticosteroids
6.2.4.1. Overview
6.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.2.5. Janus Kinase (JAK) Inhibitors
6.2.5.1. Overview
6.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.2.6. Others
6.2.6.1. Overview
6.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.3. Injectable
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.3.3. Tumor Necrosis Factor (TNF) Inhibitors
6.3.3.1. Overview
6.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.3.4. Interleukin inhibitors
6.3.4.1. Overview
6.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.3.5. Anti-integrin
6.3.5.1. Overview
6.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
6.3.6. Others
6.3.6.1. Overview
6.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
7. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET BY TYPE
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2019 & 2026 (%)
7.2. Chron's Disease
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
7.3. Ulcerative Colitis
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
7.4. Others
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET BY DISTRIBUTION CHANNEL
8.1. Overview
8.1.1. Segment Share Analysis, By Distribution Channel, 2019 & 2026 (%)
8.2. Retail Pharmacy
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.3. Hospital Pharmacy
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8.4. Online Pharmacy
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9. INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT MARKET BY GEOGRAPHY
9.1. Introduction
9.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
9.2. North America
9.2.1. Overview
9.2.2. Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
9.2.4. North America Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
9.2.5. North America Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
9.2.6. North America Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
9.2.7. U.S.
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.2.8. Canada
9.2.8.1. Overview
9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
9.3.5. Europe Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
9.3.6. Europe Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
9.3.7. Germany
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.3.8. Italy
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.3.9. United Kingdom
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.3.10. France
9.3.10.1. Overview
9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.3.11. Rest of Europe
9.3.11.1. Overview
9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
9.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
9.4.7. India
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.4.8. China
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.4.9. Japan
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.4.10. South Korea
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.4.11. Rest of APAC
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
9.5.6. Latin America Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
9.5.7. Brazil
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.5.8. Mexico
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.5.9. Argentina
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
9.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
9.6.7. Saudi Arabia
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
9.6.8. United Arab Emirates
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
10. KEY VENDOR ANALYSIS
10.1. Pfizer Inc.
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiatives
10.2. AbbVie Inc.
10.3. Cosmo Pharmaceuticals
10.4. UCB S.A.
10.5. Innovate Biopharmaceuticals
10.6. Gilead Sciences
10.7. Celgene Corporation
10.8. Celltrion Healthcare Co., Ltd.
10.9. Johnson & Johnson Services Inc.
10.10. Takeda Pharmaceutical Company Limited
11. 360 DEGREE ANALYSTVIEW
12. APPENDIX
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
